Mouse Asthma
Mouse Asthma
批准号:
7476207
负责人:
DANIEL H CONRAD
金额:
$18.59万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-01 至 2013-03-31
关键词:
AerosolsAffectAllergensAllergicAnimalsAsthmaBreathingCellsChemicalsCollaborationsCollectionConditionCore FacilityData AnalysesDevelopmentDiseaseDisease modelEffectivenessEvaluationFunctional disorderGenetic VariationHistologyHumanHypersensitivityIDEC-152 Monoclonal AntibodyIgEInfiltrationInflammationIntranasal AdministrationLaboratoriesLeadLifeLipidsLiquid substanceLungMaintenanceMeasurementMediatingMembraneMethodologyMethodsModalityModelingMonitorMusOperative Surgical ProceduresOrganOvalbuminPathologyPhenotypePhosphotransferasesPreparationProductionProtein OverexpressionRNA analysisRelative (related person)RoleRouteSPHK1 enzymeSmall Interfering RNASphingosineSymptomsSystemTestingTherapeutic InterventionToxic effectTransgenic Organismsaerosolizedchemokineconceptcytokinedayeosinophilin vivoinhibitor/antagonistknock-downknockout animalmast cellmouse modelnovelprogramsprotective effectresearch studyresponsesphingosine kinasesrc-Family Kinasestranscription factor
中文摘要
小鼠哮喘模型核心(科学核心C)将协调和执行项目中的实验
英文摘要
The mouse asthma model core (scientific core C) will coordinate and perform the experiments in projects
2, 3 and 4 that involve the mouse asthma model. In Project 4, the Leader, Dr. Spiegel, has developed
specific inhibitors for sphingosine-1-kinase and will use these in an inhalent model to get them directly to
the lung. This largely avoids systemic toxicity and targets the affected organ directly. The concept being
tested is whether inhibition of lung mast cells is sufficient to inhibit the asthma model. In addition, the
program director will use siRNA to block, in vivo, in lung the synthesis of sphingosine kinase in order to
determine whether this will inhibit asthma development. In Project 2, Dr. Conrad has demonstrated that
overexperssion of CD23 inhibits IgE production and eosinophil recruitment to the lung. Experiments will
be performed to determine if IgE is necessary for the eosinophil recruitment. In addition, the CD23
sheddase has been identified as ADAM 10 and siRNA knock-down experiments will be performed in
collaboration with Dr. Spiegel to determine if blockade of ADAM10 in the lung, either by siRNA or specific
inhibitors influences asthma development and symptoms. In Project #3, Dr. Ryan is examining the
allergic phenotype of lyn knockout animals with the objective of determining the activities of lyn in the
mast cell. The lyn"'" mice are known to develop severe Th2 disease including increased IgE and
eosinophil responses. These activities, not surprisingly, lead to a severe asthma phenotype. In
collaboration with Dr, Conrad, the lyn"'" animals will be crossed to CD23 transgenics to see if the Th2
disease is modulated. In addition, the activities of ADAM10 inhibitors either via a siRNA or chemical
inhibitor methodology, introduced directly into the lung, will be tested for capacity to modulate the lyn"'"
severe Th2 disease modality. In all of these studies, the core will provide the expertise to both perform
and analyze data from the mouse asthma model. These include maintenance of mice for the 30 day
period required for sensitization, aerosol challenge and ultimate sacrifice with BAL fluid collection and
lung preparation for histology and RNA analysis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CD23 Destabilization and IgE Regulation
-
批准号:7476201
-
项目类别:
-
资助金额:$14.0万
-
财政年份:2008
-
负责人:DANIEL H CONRAD
-
依托单位:
BIACORE 3000 : IMMUNOLOGY, PROTEIN INTERACTIONS STUDIES,; LYME DISEASE
-
批准号:7166167
-
项目类别:
-
资助金额:$9.69万
-
财政年份:2005
-
负责人:DANIEL H CONRAD
-
依托单位:
Biacore 3000 shared instrument
-
批准号:6876818
-
项目类别:
-
资助金额:$29.07万
-
财政年份:2005
-
负责人:DANIEL H CONRAD
-
依托单位:
BIACORE 3000 : PROTEIN-NUCLEIC ACID INTERACTIONS, T CRUZI STUDIES
-
批准号:7166168
-
项目类别:
-
资助金额:$9.69万
-
财政年份:2005
-
负责人:DANIEL H CONRAD
-
依托单位:
BIACORE 3000 : PROTEIN DRUG INTERACTION STUDIES
-
批准号:7166169
-
项目类别:
-
资助金额:$9.69万
-
财政年份:2005
-
负责人:DANIEL H CONRAD
-
依托单位:
FACSCALIBER
-
批准号:6440238
-
项目类别:
-
资助金额:$11.45万
-
财政年份:2002
-
负责人:DANIEL H CONRAD
-
依托单位:
IGE CONTROL BY OVEREXPRESSION OF CD23
-
批准号:6170708
-
项目类别:
-
资助金额:$25.27万
-
财政年份:1999
-
负责人:DANIEL H CONRAD
-
依托单位:
IGE CONTROL BY OVEREXPRESSION OF CD23
-
批准号:2909174
-
项目类别:
-
资助金额:$25.11万
-
财政年份:1999
-
负责人:DANIEL H CONRAD
-
依托单位:
IGE CONTROL BY OVEREXPRESSION OF CD23
-
批准号:6632160
-
项目类别:
-
资助金额:$26.22万
-
财政年份:1999
-
负责人:DANIEL H CONRAD
-
依托单位:
IGE CONTROL BY OVEREXPRESSION OF CD23
-
批准号:6511121
-
项目类别:
-
资助金额:$25.45万
-
财政年份:1999
-
负责人:DANIEL H CONRAD
-
依托单位:
IGE CONTROL BY OVEREXPRESSION OF CD23
-
批准号:6374016
-
项目类别:
-
资助金额:$24.71万
-
财政年份:1999
-
负责人:DANIEL H CONRAD
-
依托单位:
Training in Hypersensitivity and Cancer Immunology
-
批准号:6499996
-
项目类别:
-
资助金额:$16.1万
-
财政年份:1992
-
负责人:DANIEL H CONRAD
-
依托单位:
TRAINING IN HYPERSENSITIVITY AND ANTIGEN PROCESSING
-
批准号:2058287
-
项目类别:
-
资助金额:$9.69万
-
财政年份:1992
-
负责人:DANIEL H CONRAD
-
依托单位:
TRAINING IN HYPERSENSITIVITY AND ANTIGEN PROCESSING
-
批准号:2058290
-
项目类别:
-
资助金额:$9.59万
-
财政年份:1992
-
负责人:DANIEL H CONRAD
-
依托单位:
TRAINING IN HYPERSENSITIVITY AND ANTIGEN PROCESSING
-
批准号:2671552
-
项目类别:
-
资助金额:$9.75万
-
财政年份:1992
-
负责人:DANIEL H CONRAD
-
依托单位:
Training in Hypersensitivity and Cancer Immunology
-
批准号:6940592
-
项目类别:
-
资助金额:$16.36万
-
财政年份:1992
-
负责人:DANIEL H CONRAD
-
依托单位:
TRAINING IN HYPERSENSITIVITY AND ANTIGEN PROCESSING
-
批准号:6372796
-
项目类别:
-
资助金额:$12.25万
-
财政年份:1992
-
负责人:DANIEL H CONRAD
-
依托单位:
TRAINING IN HYPERSENSITIVITY AND ANTIGEN PROCESSING
-
批准号:2330281
-
项目类别:
-
资助金额:$9.6万
-
财政年份:1992
-
负责人:DANIEL H CONRAD
-
依托单位:
Training in Hypersensitivity and Cancer Immunology
-
批准号:6652439
-
项目类别:
-
资助金额:$13.87万
-
财政年份:1992
-
负责人:DANIEL H CONRAD
-
依托单位:
TRAINING IN HYPERSENSITIVITY AND ANTIGEN PROCESSING
-
批准号:2058289
-
项目类别:
-
资助金额:$10.45万
-
财政年份:1992
-
负责人:DANIEL H CONRAD
-
依托单位:
海外基金